These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

760 related items for PubMed ID: 10603113

  • 21. Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients.
    Smith JM, Corey L, Healey PJ, Davis CL, McDonald RA.
    Transplantation; 2007 Jun 15; 83(11):1423-8. PubMed ID: 17565314
    [Abstract] [Full Text] [Related]

  • 22. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
    Shapiro R, Nalesnik M, McCauley J, Fedorek S, Jordan ML, Scantlebury VP, Jain A, Vivas C, Ellis D, Lombardozzi-Lane S, Randhawa P, Johnston J, Hakala TR, Simmons RL, Fung JJ, Starzl TE.
    Transplantation; 1999 Dec 27; 68(12):1851-4. PubMed ID: 10628763
    [Abstract] [Full Text] [Related]

  • 23. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients.
    Colombini E, Guzzo I, Morolli F, Longo G, Russo C, Lombardi A, Merli P, Barzon L, Murer L, Piga S, Ciofi Degli Atti ML, Locatelli F, Dello Strologo L.
    Pediatr Nephrol; 2017 Aug 27; 32(8):1433-1442. PubMed ID: 28280938
    [Abstract] [Full Text] [Related]

  • 24. Graft rejection in pediatric liver transplant patients with Epstein-Barr viremia and post-transplant lymphoproliferative disease.
    Weiner C, Weintraub L, Wistinghausen B, Tomaino J, Arnon R, Kerkar N, Miloh T.
    Pediatr Transplant; 2012 Aug 27; 16(5):458-64. PubMed ID: 22554096
    [Abstract] [Full Text] [Related]

  • 25. Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.
    Zimmermann H, Oschlies I, Fink S, Pott C, Neumayer HH, Lehmkuhl H, Hauser IA, Dreyling M, Kneba M, Gärtner B, Anagnostopoulos I, Riess H, Klapper W, Trappe RU.
    Transplantation; 2012 Mar 15; 93(5):543-50. PubMed ID: 22234349
    [Abstract] [Full Text] [Related]

  • 26. Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients.
    Merlino C, Cavallo R, Bergallo M, Giacchino F, Bollero C, Negro Ponzi A, Cavallo G.
    New Microbiol; 2003 Apr 15; 26(2):141-9. PubMed ID: 12737195
    [Abstract] [Full Text] [Related]

  • 27. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
    Wu JF, Ho MC, Ni YH, Chen HL, Lu CY, Hsu HY, Lee PH, Chang MH.
    Transplantation; 2009 Mar 15; 87(5):758-62. PubMed ID: 19295323
    [Abstract] [Full Text] [Related]

  • 28. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Franco A, Jiménez L, Aranda I, Alvarez L, González M, Rocamora N, Olivares J.
    Nefrologia; 2002 Mar 15; 22(5):463-9. PubMed ID: 12497748
    [Abstract] [Full Text] [Related]

  • 29. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD.
    D'Antiga L, Del Rizzo M, Mengoli C, Cillo U, Guariso G, Zancan L.
    Liver Transpl; 2007 Mar 15; 13(3):343-8. PubMed ID: 17154402
    [Abstract] [Full Text] [Related]

  • 30. Post-transplantation lymphoproliferative disorder in pediatric kidney-transplant recipients - a national study.
    Cleper R, Ben Shalom E, Landau D, Weissman I, Krause I, Konen O, Rahamimov R, Mor E, Bar-Nathan N, Frishberg Y, Davidovits M.
    Pediatr Transplant; 2012 Sep 15; 16(6):619-26. PubMed ID: 22708682
    [Abstract] [Full Text] [Related]

  • 31. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E, Özdemir BH, Deniz EE, Tunca MZ, Haberal M.
    Exp Clin Transplant; 2014 Mar 15; 12 Suppl 1():142-8. PubMed ID: 24635813
    [Abstract] [Full Text] [Related]

  • 32. Identifying predictive factors for posttransplant lymphoproliferative disease in pediatric solid organ transplant recipients with Epstein-Barr virus viremia.
    Weintraub L, Weiner C, Miloh T, Tomaino J, Joashi U, Benchimol C, Strauchen J, Roth M, Wistinghausen B.
    J Pediatr Hematol Oncol; 2014 Nov 15; 36(8):e481-6. PubMed ID: 24878618
    [Abstract] [Full Text] [Related]

  • 33. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.
    Kinch A, Baecklund E, Backlin C, Ekman T, Molin D, Tufveson G, Fernberg P, Sundström C, Pauksens K, Enblad G.
    Acta Oncol; 2014 May 15; 53(5):669-79. PubMed ID: 24164103
    [Abstract] [Full Text] [Related]

  • 34. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
    Gross TG, Bucuvalas JC, Park JR, Greiner TC, Hinrich SH, Kaufman SS, Langnas AN, McDonald RA, Ryckman FC, Shaw BW, Sudan DL, Lynch JC.
    J Clin Oncol; 2005 Sep 20; 23(27):6481-8. PubMed ID: 16170157
    [Abstract] [Full Text] [Related]

  • 35. Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.
    Calabrese F, Loy M, Lunardi F, Marino D, Aversa SM, Rea F.
    Transpl Infect Dis; 2010 Aug 01; 12(4):342-6. PubMed ID: 20030794
    [Abstract] [Full Text] [Related]

  • 36. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience.
    Kogan-Liberman D, Burroughs M, Emre S, Moscona A, Shneider BL.
    J Pediatr Gastroenterol Nutr; 2001 Oct 01; 33(4):445-9. PubMed ID: 11698761
    [Abstract] [Full Text] [Related]

  • 37. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
    Guthery SL, Heubi JE, Bucuvalas JC, Gross TG, Ryckman FC, Alonso MH, Balistreri WF, Hornung RW.
    Transplantation; 2003 Apr 15; 75(7):987-93. PubMed ID: 12698085
    [Abstract] [Full Text] [Related]

  • 38. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
    Mendoza F, Kunitake H, Laks H, Odim J.
    Pediatr Transplant; 2006 Feb 15; 10(1):60-6. PubMed ID: 16499589
    [Abstract] [Full Text] [Related]

  • 39. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
    Omar H, Hägglund H, Gustafsson-Jernberg A, LeBlanc K, Mattsson J, Remberger M, Ringdén O, Sparrelid E, Sundin M, Winiarski J, Yun Z, Ljungman P.
    Transpl Infect Dis; 2009 Oct 15; 11(5):393-9. PubMed ID: 19497070
    [Abstract] [Full Text] [Related]

  • 40. Long-term survival after post-transplant lymphoproliferative disease in children.
    Nathanson S, Debray D, Delarue A, Deschênes G.
    Pediatr Nephrol; 2002 Aug 15; 17(8):668-72. PubMed ID: 12185479
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.